Latest News

As the Australian market faces a slightly lower opening amid global tech sector challenges, investors are increasingly cautious, influenced by Wall Street's recent downturn and upcoming central bank meetings. In this climate, growth companies with high insider ownership can be particularly appealing as they often signal strong internal confidence and alignment with shareholder interests.

As the Australian stock market opens slightly lower today, influenced by ongoing challenges in the U.S. tech sector and cautious global sentiment, investors are keenly observing potential opportunities amidst this volatility. In such an environment, identifying undervalued stocks can be crucial for those looking to capitalize on market inefficiencies and long-term growth potential.

AGCO Corporation ( NYSE:AGCO ) has announced that it will pay a dividend of $0.29 per share on the 16th of March...

Australian shares are expected to open slightly lower today, with futures indicating a modest drop, as global market sentiment remains cautious amid ongoing challenges in the tech sector. For investors willing to explore beyond well-known companies, penny stocks—typically smaller or newer firms—can offer intriguing possibilities. Despite being an older term, penny stocks still hold potential for growth and affordability when backed by strong financials; we'll explore three such examples that...

The subdued stock price reaction suggests that Extreme Networks, Inc.'s ( NASDAQ:EXTR ) strong earnings didn't offer...

Duolingo, Inc. ( NASDAQ:DUOL ) shareholders that were waiting for something to happen have been dealt a blow with a 37...

EPAM Systems (EPAM) is back in focus after supporting Agentathon, billed as the world’s largest agentic AI hackathon, and expanding its role as digital transformation partner to the National Geographic Society. See our latest analysis for EPAM Systems. These AI and digital transformation projects arrive against a mixed return profile, with the share price at US$184.78 and recent 7-day and 30-day share price returns weaker, even as the 90-day share price return is positive and multi year total...

Clarivate (CLVT) is drawing fresh attention after announcing an “Intelligence Amplified in the Age of AI” webinar, where CEO Matti Shem Tov will walk through new AI tools built on the company’s proprietary, curated data. See our latest analysis for Clarivate. The AI webinar comes shortly after Clarivate used cash on hand to redeem the remaining US$100 million of its 4.50% senior secured notes due 2026. However, the 30 day share price return of 36% and 1 year total shareholder return of 58%...

Mie Kotsu Group Holdings (TSE:3232) has just posted its Q3 2026 numbers, with revenue of ¥26.9 billion and basic EPS of ¥21.01, against a backdrop of one year EPS growth of 6.8% and net profit margins at 5.9%, up from 5.6% over the last 12 months. The company has seen quarterly revenue move from ¥24.9 billion in Q3 2025 to ¥26.9 billion in Q3 2026, while basic EPS over that period shifted from ¥18.50 to ¥21.01, framing this release as part of a steady earnings story that depends on whether...

If you are wondering whether D.R. Horton stock is offering fair value at current levels, it helps to step back and look at what the market has been pricing in recently. The share price recently closed at US$158.22, with returns of 5.4% over 7 days, 8.0% over 30 days, 8.6% year to date, 15.6% over 1 year, 67.3% over 3 years, and 102.0% over 5 years. This sets the backdrop for any valuation check you might run. Recent headlines around D.R. Horton have focused on its position within US...

If you are asking whether Johnson & Johnson’s current share price still offers value, you are not alone. That is exactly what this article is going to unpack for you. The stock last closed at US$234.47, with returns of 3.0% over 7 days, 14.8% over 30 days, 13.1% year to date, 56.2% over 1 year, 57.0% over 3 years, and 62.0% over 5 years. This naturally raises questions about how the recent performance lines up with underlying value. Recent news around Johnson & Johnson has focused on its...

In January, Edison International filed to securitize about US$1.95 billion in Woolsey fire-related expenses to help reduce debt and support investment at its Southern California utility subsidiary. An interesting angle is that these securitization efforts come as UBS expects California’s Phase 2 wildfire mitigation policy to further support Edison International’s financial stability. With this backdrop of wildfire cost securitization, we’ll now examine how these developments shape Edison...

Kakaku.com (TSE:2371) has reported Q3 2026 revenue of ¥24,030 million and basic EPS of ¥25.28, with trailing 12 month revenue at ¥90,639 million and EPS at ¥97.59 anchoring the latest numbers. The company has seen quarterly revenue move from ¥20,324 million in Q3 2025 to ¥24,030 million in Q3 2026, while basic EPS shifted from ¥27.86 to ¥25.28 over the same period, setting up a results season in which investors are likely to focus on how these earnings relate to margins and future...

Core & Main stock reaction and recent performance snapshot Core & Main (CNM) shares recently closed at $56.52, with the move coming alongside a return of about 2% over the past month and roughly 11% over the past 3 months. See our latest analysis for Core & Main. The recent 10.61% three-month share price return, alongside a 5.82% year-to-date share price return and a very large three-year total shareholder return of around 7x, suggests momentum has been building over a multi-year period...

Simon Property Group (SPG) has drawn fresh attention after reporting record real estate funds from operations, strong leasing and occupancy, extensive redevelopment activity, and a higher quarterly dividend heading into 2026. See our latest analysis for Simon Property Group. At a share price of $195.59, Simon Property Group has seen short term momentum with a 1 month share price return of 6.82% and a steadier build up over time, reflected in a 1 year total shareholder return of 14.74% and a 5...

Why AstraZeneca (LSE:AZN) Is Drawing Attention Now AstraZeneca (LSE:AZN) has been on investors’ radar after a period of mixed shorter term returns, with the share price roughly flat over the past month but higher over the past 3 months and year. At a last close of £139.80 and a reported intrinsic discount of 44%, the stock is prompting fresh interest from investors who are comparing recent share performance with the company’s current earnings profile and business scale. See our latest...

Trump Media & Technology Group Corp. recently confirmed that February 2, 2026, remains the official record date for its digital token initiative, with any shareholder owning at least one share on that date eligible for token-related incentives tied to its products and exclusive events. This move highlights how Trump Media is experimenting with token-based rewards to deepen shareholder engagement and link ownership to platform-specific benefits. Next, we’ll examine how cementing the February...

Cube System (TSE:2335) Q3 2026 results at a glance Cube System (TSE:2335) has put fresh numbers on the table for Q3 2026, reporting revenue of ¥4,617 million and net income of ¥522 million, which translates to basic EPS of ¥34.39. Over recent quarters the company has seen revenue move in a tight band around the ¥4,600 million level. EPS stepped from ¥16.07 in Q2 2025 to ¥23.48 in Q2 2026 and now ¥34.39 in Q3 2026, with trailing twelve month EPS at ¥94.96. With earnings over the last year up...

The New York Times Company recently reported its fourth-quarter and full-year 2025 results, with revenue rising to US$802.31 million for the quarter and US$2.82 billion for the year, alongside higher net income and earnings per share than in 2024. Beneath the headline growth, investors focused on higher operating costs tied partly to AI copyright litigation and on how increased spending might affect the profitability of the company’s expanding digital subscription and advertising...

Molina Healthcare, a managed care insurer focused on government programs, reported its fourth-quarter 2025 results on February 5, 2026, amid concerns about rising medical costs, lower investment income, and shifting membership trends across Medicaid, Medicare, and marketplace plans. While the company previously beat revenue expectations and is projected to see Medicare and marketplace membership growth, analysts remain cautious as Medicaid membership is expected to fall and the medical care...

If you are wondering whether CAVA Group’s current share price lines up with its underlying worth, this article is designed to walk you through that question step by step. The stock last closed at US$65.41, with returns of 4.3% over the past week, 3.0% over the last month, 8.0% year to date, and a 54.2% decline over the past year. This points to mixed sentiment and shifting expectations. Recent coverage has focused on CAVA Group’s position within the US consumer services space and how...

In late 2025, Baron Discovery Fund highlighted Establishment Labs Holdings’ Motiva breast implants as a key contributor, citing lower safety risks, aesthetic benefits, and a solid ongoing U.S. aesthetic market launch, while the company reported record quarterly revenue and continued positive adjusted EBITDA. Investor attention has centered on Establishment Labs’ progress toward potential U.S. breast reconstruction approval and its goal of reaching free cash flow positivity, which together...

Techno Medica (TSE:6678) has put up another solid set of numbers for Q3 2026, with revenue at ¥3.1 billion and basic EPS of ¥37.01, as net income excluding extra items came in at ¥257 million. The company has seen quarterly revenue move from ¥2.1 billion in Q1 2026 to ¥2.3 billion in Q2 and now ¥3.1 billion in Q3, while basic EPS stepped from ¥14.66 to ¥26.97 to ¥37.01 over the same stretch. This is setting the stage for investors to focus closely on how sustainable these earnings and the...

Br. Holdings (TSE:1726) just posted its Q3 2026 numbers, with revenue of ¥8.7b and basic EPS of ¥11.33, giving investors a clear read on how the business is currently earning its way through the year. The company has seen quarterly revenue move from ¥10.8b in Q2 2025 to ¥10.6b in Q3 2025, then to ¥10.2b in Q4 2025 and ¥8.7b by Q3 2026. Basic EPS has ranged from ¥5.77 in Q2 2025 and around ¥10 in Q3 and Q4 2025 to ¥2.52 in Q1 2026, ¥2.77 in Q2 2026 and ¥11.33 this quarter. This sets up a...